Gastrointestinal uptake of biodegradable microparticles: Effect of particle size

被引:758
作者
Desai, MP
Labhasetwar, V
Amidon, GL
Levy, RJ
机构
[1] UNIV MICHIGAN,DIV PEDIAT CARDIOL,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109
关键词
oral; drug delivery; nanoparticles; Peyer's patches; size exclusion; vaccine;
D O I
10.1023/A:1016085108889
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To investigate the effect of microparticle size on gastrointestinal tissue uptake. Methods. Biodegradable microparticles of various sizes using polylactic polyglycolic acid (50:50) co-polymer (100 nm, 500 nm, 1 mu m, and 10 mu m) and bovine serum albumin as a model protein were formulated by water-in-oil-in-water emulsion solvent evaporation technique. The uptake of microparticles was studied in rat in situ intestinal loop model and quantitatively analyzed for efficiency of uptake. Results. In general, the efficiency of uptake of 100 nm size particles by the intestinal tissue was 15-250 fold higher compared to larger size microparticles. The efficiency of uptake was dependent on the type of tissue, such as Peyer's patch and non patch as well as on the location of the tissue collected i.e, duodenum or ileum. Depending on the size of microparticles, the Peyer's patch tissue had 2-200 fold higher uptake of particles than the non-patch tissue collected from the same region of the intestine. Histological evaluation of the tissue sections demonstrated that 100 nm particles were diffused throughout the submucosal layers while the larger size nano/microparticles were predominantly localized in the epithelial lining of the tissue. Conclusions. There is a microparticle size dependent exclusion phenomena in the gastrointestinal mucosal tissue with 100 nm size particles showing significantly greater tissue uptake. This has important implications in designing of nanoparticle-based oral drug delivery systems, such as an oral vaccine system.
引用
收藏
页码:1838 / 1845
页数:8
相关论文
共 30 条
  • [1] Acute gastrointestinal toxic effects of suspensions of unencapsulated and encapsulated ibuprofen in rats
    Adeyeye, CM
    Bricker, JD
    Vilivalam, VD
    Smith, WI
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (05) : 784 - 793
  • [2] THE TRANSPORT OF MICROSPHERES FROM THE GASTROINTESTINAL-TRACT TO INFLAMMATORY AIR POUCHES IN THE RAT
    ALPAR, HO
    FIELD, WN
    LEWIS, DA
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (03) : 194 - 196
  • [3] TRANSMUCOSAL PASSAGE OF POLYALKYLCYANOACRYLATE NANOCAPSULES AS A NEW DRUG CARRIER IN THE SMALL-INTESTINE
    APRAHAMIAN, M
    MICHEL, C
    HUMBERT, W
    DEVISSAGUET, JP
    DAMGE, C
    [J]. BIOLOGY OF THE CELL, 1987, 61 (1-2) : 69 - 76
  • [4] ADSORPTION OF ANTI-NEOPLASTIC DRUGS TO POLYALKYLCYANOACRYLATE NANOPARTICLES AND THEIR RELEASE IN CALF SERUM
    COUVREUR, P
    KANTE, B
    ROLAND, M
    SPEISER, P
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : 1521 - 1524
  • [5] Couvreur P, 1984, MICROSPHERES DRUG TH, p[103, 103]
  • [6] ORAL INDUCTION OF THE SECRETORY ANTIBODY-RESPONSE BY SOLUBLE AND PARTICULATE ANTIGENS
    COX, DS
    TAUBMAN, MA
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1984, 75 (02): : 126 - 131
  • [7] NANOCAPSULES AS CARRIERS FOR ORAL PEPTIDE DELIVERY
    DAMGE, C
    MICHEL, C
    APRAHAMIAN, M
    COUVREUR, P
    DEVISSAGUET, JP
    [J]. JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) : 233 - 239
  • [8] A METHOD FOR QUANTIFYING PARTICLE ABSORPTION FROM THE SMALL-INTESTINE OF THE MOUSE
    EBEL, JP
    [J]. PHARMACEUTICAL RESEARCH, 1990, 7 (08) : 848 - 851
  • [9] CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES
    ELDRIDGE, JH
    HAMMOND, CJ
    MEULBROEK, JA
    STAAS, JK
    GILLEY, RM
    TICE, TR
    [J]. JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) : 205 - 214
  • [10] BIODEGRADABLE MICROSPHERES AS A VACCINE DELIVERY SYSTEM
    ELDRIDGE, JH
    STAAS, JK
    MEULBROEK, JA
    MCGHEE, JR
    TICE, TR
    GILLEY, RM
    [J]. MOLECULAR IMMUNOLOGY, 1991, 28 (03) : 287 - 294